vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $252.5M, roughly 2.0× USA Compression Partners, LP). USA Compression Partners, LP runs the higher net margin — 11.0% vs 6.8%, a 4.2% gap on every dollar of revenue. On growth, USA Compression Partners, LP posted the faster year-over-year revenue change (2.7% vs -1.7%). Over the past eight quarters, USA Compression Partners, LP's revenue compounded faster (4.9% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

MD vs USAC — Head-to-Head

Bigger by revenue
MD
MD
2.0× larger
MD
$493.8M
$252.5M
USAC
Growing faster (revenue YoY)
USAC
USAC
+4.4% gap
USAC
2.7%
-1.7%
MD
Higher net margin
USAC
USAC
4.2% more per $
USAC
11.0%
6.8%
MD
Faster 2-yr revenue CAGR
USAC
USAC
Annualised
USAC
4.9%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
USAC
USAC
Revenue
$493.8M
$252.5M
Net Profit
$33.7M
$27.8M
Gross Margin
Operating Margin
9.9%
30.3%
Net Margin
6.8%
11.0%
Revenue YoY
-1.7%
2.7%
Net Profit YoY
10.5%
9.1%
EPS (diluted)
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
USAC
USAC
Q4 25
$493.8M
$252.5M
Q3 25
$492.9M
$250.3M
Q2 25
$468.8M
$250.1M
Q1 25
$458.4M
$245.2M
Q4 24
$502.4M
$245.9M
Q3 24
$511.2M
$240.0M
Q2 24
$504.3M
$235.3M
Q1 24
$495.1M
$229.3M
Net Profit
MD
MD
USAC
USAC
Q4 25
$33.7M
$27.8M
Q3 25
$71.7M
$34.5M
Q2 25
$39.3M
$28.6M
Q1 25
$20.7M
$20.5M
Q4 24
$30.5M
$25.4M
Q3 24
$19.4M
$19.3M
Q2 24
$-153.0M
$31.2M
Q1 24
$4.0M
$23.6M
Operating Margin
MD
MD
USAC
USAC
Q4 25
9.9%
30.3%
Q3 25
13.8%
33.5%
Q2 25
12.8%
30.6%
Q1 25
7.0%
28.3%
Q4 24
7.8%
30.3%
Q3 24
6.6%
31.5%
Q2 24
-31.3%
32.9%
Q1 24
3.2%
29.2%
Net Margin
MD
MD
USAC
USAC
Q4 25
6.8%
11.0%
Q3 25
14.5%
13.8%
Q2 25
8.4%
11.4%
Q1 25
4.5%
8.4%
Q4 24
6.1%
10.3%
Q3 24
3.8%
8.1%
Q2 24
-30.3%
13.3%
Q1 24
0.8%
10.3%
EPS (diluted)
MD
MD
USAC
USAC
Q4 25
$0.40
Q3 25
$0.84
Q2 25
$0.46
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$375.2M
$8.6M
Total DebtLower is stronger
$570.5M
$2.5B
Stockholders' EquityBook value
$865.9M
Total Assets
$2.2B
$2.6B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
USAC
USAC
Q4 25
$375.2M
$8.6M
Q3 25
$340.1M
Q2 25
$224.7M
$2.0K
Q1 25
$99.0M
$2.0K
Q4 24
$229.9M
$14.0K
Q3 24
$103.8M
$79.0K
Q2 24
$19.4M
$9.0K
Q1 24
$8.0M
$8.0K
Total Debt
MD
MD
USAC
USAC
Q4 25
$570.5M
$2.5B
Q3 25
$577.2M
$2.5B
Q2 25
$583.9M
$2.5B
Q1 25
$590.5M
$2.5B
Q4 24
$597.1M
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
MD
MD
USAC
USAC
Q4 25
$865.9M
Q3 25
$890.7M
Q2 25
$833.8M
Q1 25
$789.2M
Q4 24
$764.9M
Q3 24
$732.5M
Q2 24
$706.5M
Q1 24
$856.2M
Total Assets
MD
MD
USAC
USAC
Q4 25
$2.2B
$2.6B
Q3 25
$2.2B
$2.7B
Q2 25
$2.1B
$2.7B
Q1 25
$2.0B
$2.7B
Q4 24
$2.2B
$2.7B
Q3 24
$2.1B
$2.8B
Q2 24
$2.0B
$2.8B
Q1 24
$2.2B
$2.8B
Debt / Equity
MD
MD
USAC
USAC
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
USAC
USAC
Operating Cash FlowLast quarter
$114.1M
$139.5M
Free Cash FlowOCF − Capex
$87.7M
FCF MarginFCF / Revenue
34.8%
Capex IntensityCapex / Revenue
20.5%
Cash ConversionOCF / Net Profit
3.39×
5.02×
TTM Free Cash FlowTrailing 4 quarters
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
USAC
USAC
Q4 25
$114.1M
$139.5M
Q3 25
$137.3M
$75.9M
Q2 25
$137.2M
$124.2M
Q1 25
$-117.5M
$54.7M
Q4 24
$133.0M
$130.2M
Q3 24
$91.8M
$48.5M
Q2 24
$107.0M
$96.7M
Q1 24
$-125.2M
$65.9M
Free Cash Flow
MD
MD
USAC
USAC
Q4 25
$87.7M
Q3 25
$51.9M
Q2 25
$101.1M
Q1 25
$36.3M
Q4 24
$101.2M
Q3 24
$19.8M
Q2 24
$48.2M
Q1 24
$-32.7M
FCF Margin
MD
MD
USAC
USAC
Q4 25
34.8%
Q3 25
20.7%
Q2 25
40.4%
Q1 25
14.8%
Q4 24
41.1%
Q3 24
8.2%
Q2 24
20.5%
Q1 24
-14.3%
Capex Intensity
MD
MD
USAC
USAC
Q4 25
20.5%
Q3 25
9.6%
Q2 25
9.3%
Q1 25
7.5%
Q4 24
11.8%
Q3 24
12.0%
Q2 24
20.6%
Q1 24
43.0%
Cash Conversion
MD
MD
USAC
USAC
Q4 25
3.39×
5.02×
Q3 25
1.91×
2.20×
Q2 25
3.49×
4.35×
Q1 25
-5.66×
2.66×
Q4 24
4.36×
5.12×
Q3 24
4.72×
2.51×
Q2 24
3.10×
Q1 24
-31.03×
2.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons